Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Follow us on Google+Follow us on TwitterFind us on LinkedInFind Us on FacebookSubscribe to our RSS FeedsSubscribe to our YouTube ChannelFind us on RebelMouse

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for January 08, 2014 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version   



Ensil Canada is Launching a New Medical Device: Publicly Traded Companies Are Invited to Acquire This Technology or Partner with Ensil Canada on the Marketing and Distribution of This New Device

This new medical device, called Vastusys, is able to help people with mobility issues caused by spinal cord injuries, strokes or muscular disorders.
 
x-small text small text medium text large text

Ensil is inviting publicly traded companies to express interest in either acquiring its new medical technology or partnering with Ensil to market and/or distribute it in key markets.

    NEW YORK, NY, January 08, 2014 /24-7PressRelease/ -- Ensil's team of researchers and engineers have developed a medical device with patented technology that will help patients who suffer from mobility issues caused by spinal cord injuries, strokes or muscle disorders.

This product is called Vastusys (www.vastusys.com), and it works by replicating normal communication between the brain and the limbs via a proprietary, patented technology developed by Ensil. The product utilizes Ensil's innovative bluetooth protocol technology and multiple sensors to enable muscle movement and improve mobility.

"This is truly a ground-breaking achievement that will improve the lives of so many people," said Mr. Farsad Kiani, CEO of Ensil Canada. "I am excited to extend an open invitation to publicly traded companies to either acquire this technology or partner with Ensil to market and distribute this medical device to people around the world."

Ensil is currently inviting publicly traded companies to express interest in either acquiring the new technology or partnering with Ensil on the marketing and/or distribution of the Vastusys medical device.

Ensil Canada is a member of the Ensil group of companies (www.ensil.com), and it focuses on enhancing mission-critical technologies in the areas of Aerospace, Defence and Medical Diagnostic Equipment. Ensil's Research and Development division's mission is to develop new technologies or improve existing technologies, leveraging its in-house aerospace, defence and medical technology expertise, research and resources.

For nearly 30 years, a fundamental belief in "Innovation Beyond Imagination" has been part of Ensil's corporate culture. Since its inception, the company has built its brand in the North American Aerospace and Defence industries as a boutique engineering and R&D technology leader that is striving to improve the quality of life of people globally via innovative ideas and technologies.



---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #



Contact Information:
Farsad Kiani
Ensil Canada Ltd.

Markham, ON
Canada
Voice: 905-479-6979 x 801
E-Mail: Email us Here
Website: Visit Our Website
Follow Us:
 Follow Us on LinkedIn
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7PressRelease. We are unable to assist you with any information regarding this release. 24-7PressRelease disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.